Cancer Clinical Trial
Official title:
Physical Activity and Its Components in Relation to Plasma Inflammatory Markers of Cancer Risk Among Chinese Adults
| Verified date | September 2020 |
| Source | National Institutes of Health Clinical Center (CC) |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This protocol is a sub-study of the ongoing "Protect Health and Reduce Cancer Risk" study
conducted in Shanghai, China, and sponsored by the Shanghai Cancer Institute, Vanderbilt
University, and the National Cancer Institute. The parent study is designed to examine the
relationship of diet, lifestyle, occupational, and environmental risk factors, as well as
genetic variation, to cancer incidence in a large cohort of men in women between 40 and 70
years of age. The current sub-study will assess the validity and reliability of a new
physical activity questionnaire for use in the parent study and to evaluate whether different
types of activity and the frequency, intensity, and duration of activity are associated with
markers that have been linked to cancer risk, such as C-reactive protein, interleukin 6 and
soluble tumor necrosis factor alpha.
Participants in the current 12-month study are selected from among men and women
participating in the "Protect Health and Reduce Cancer Risk" study. Participants keep a diary
of their physical activity and complete two 30-minute interviews about their physical
activity, one at the beginning and one at the end of the study period. Every 3 months for 7
consecutive days, they wear a pager-sized activity monitor on their waist that records their
physical activity patterns during that period of time. They provide blood and urine samples
four times during the study and, at the end of the study, undergo a health examination that
includes an electrocardiogram, body composition measurement, and physical fitness test. The
fitness test is a step-test consisting of 3-minute stages in which the subject successively
increases the stepping speed until reaching 85 percent of his or her predicted maximal heart
rate.
Blood and urine samples are analyzed for levels of nutrients and certain proteins, and are
stored for future studies related to nutrition and physical activity and possibly for genetic
studies related to health, nutrition, exercise, or disease.
| Status | Completed |
| Enrollment | 620 |
| Est. completion date | April 23, 2009 |
| Est. primary completion date | April 23, 2009 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 45 Years to 75 Years |
| Eligibility |
- INCLUSION CRITERIA: The current study will be conducted in random sub samples of the Shanghai Women's Cohort Study and Shanghai Men's Cohort Study. Eligibility in these 2 cohort studies was determined based on the following: 40 to 70 years of age and residing in one of 7 Shanghai urban areas that is representative of all of urban Shanghai. Both women and men will be included in the study. No exclusions will be made by race, although it should be noted that the study population of the Shanghai Women's Cohort and Shanghai Men's Cohort Study is virtually 100% Asian. EXCLUSION CRITERIA: There wil be no prior from participation, other than the presence of physical ailments preventing subjects from participating in the study. Before participating in the fitness test, subjects will be screened for cardiovascular disease, othopedic limitations, or other factors that contraindicate testing, including pregnancy, respiratory problems at rest (labored breathing or persistent cough), presence of illness or fever, or swelling of the lower extremities. In addition, participants who do not adhere to the pre-test instructions of not eating heavily or drinking alcohol 2 hours before the test will be excluded from performing the fitness test. Children will not be included in the current study, because study subjects are comprised of participants in the Shanghai Womens's Cohort Study and the Shanghai Men's Cohort Study, who are 40 to 70 years of age. |
| Country | Name | City | State |
|---|---|---|---|
| China | Shanghai National Cancer Institute | Shanghai | |
| United States | Vanderbilt University | Nashville | Tennessee |
| Lead Sponsor | Collaborator |
|---|---|
| National Cancer Institute (NCI) | Vanderbilt University |
United States, China,
Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):287-301. Review. — View Citation
McTiernan A, Ulrich C, Slate S, Potter J. Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control. 1998 Oct;9(5):487-509. Review. — View Citation
Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. 2001 Mar;131(3):871S-873S. Review. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Physical activity behaviors and circulating or excreted biomarkers | Biomarkers | 1 Year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|